CAS number: 50629-82-8

General information about the Halometasone Monohydrate active pharmaceutical ingredient

Halometasone Monohydrate as active pharmaceutical ingredient (API) is a potent corticosteroid or steroid, class of glucocorticoid, is used topically to treat a variety of skin conditions such as eczema, dermatitis, allergies, and rashes. Halometasone Monohydrate API that inhibits inflammation, epidermal hyperplasia, and allergic reactions, constrict blood vessels and relieve pruritus. Halometasone Monohydrate is available as a cream, ointment. Halometasone Monohydrate is used in combination with antimicrobials to treat bacterial skin infections such as impetigo, folliculitis, paronychia, sycosis barbae, and erythrasma.

Axplora manufactures Halometasone Monohydrate API

Halometasone Monohydrate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Halometasone Monohydrate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Halometasone Monohydrate API is commercially available as micronized grade specifically designed around various formulation requirements.Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Halometasone Monohydrate API.
  • Therapeutic area Dermatologic
  • Monograph INTERNAL
  • Available grade Micronized
  • Regulatory documentation EU DMF
  • Produced in GRO